Related Experiment Video

Updated: May 9, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1

Jian-Qiang Xu1, Ping Liu, Ming-Jue Si

  • 1Department of Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine No.197, Ruijin 2nd Road, Shanghai, China, 200025.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|July 24, 2013
PubMed

Insights

MicroRNA-126 (miR-126) is downregulated in osteosarcoma, inhibiting cancer cell proliferation. Its restoration suppresses tumor growth by negatively regulating Sirt1 expression in osteosarcoma cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in human cancer development, proliferation, and metastasis.
  • Understanding specific miRNA roles in osteosarcoma is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the functional role of miR-126 in osteosarcoma (OS) cells.
  • To identify potential target genes of miR-126 in OS.

Main Methods:

  • Quantitative analysis of miR-126 expression in OS cells versus normal tissues.
  • Functional assays assessing cell proliferation upon miR-126 modulation (enforced expression or antisense inhibition).
  • Molecular analysis to identify miR-126 targets, focusing on Sirt1 (histone deacetylase).

Main Results:

  • miR-126 expression was significantly reduced in osteosarcoma tissues compared to adjacent normal tissues.
  • Enforced miR-126 expression inhibited proliferation of U2OS and MG63 osteosarcoma cell lines.
  • miR-126 antisense oligonucleotides promoted osteosarcoma cell proliferation.
  • Sirt1 expression was found to be negatively regulated by miR-126.

Conclusions:

  • miR-126 acts as a tumor suppressor in osteosarcoma.
  • The miR-126/Sirt1 axis is a key regulatory pathway in osteosarcoma progression.
  • These findings highlight miR-126 as a potential therapeutic target for osteosarcoma.

More Related Videos

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells05:16

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells

Published on: December 30, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...